Response to trametinib of histiocytosis with an activating PTPN11 mutation

Leuk Lymphoma. 2020 Jan;61(1):194-197. doi: 10.1080/10428194.2019.1650175. Epub 2019 Aug 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Histiocytosis*
  • Humans
  • Mutation
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11 / genetics
  • Pyridones / therapeutic use
  • Pyrimidinones* / therapeutic use

Substances

  • Pyridones
  • Pyrimidinones
  • trametinib
  • PTPN11 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11